nicht mehr verfügbar

EA101052 Anti-Bordetella pertussis IgG ELISA Kit

Search for all "Anti-Bordetella pertussis IgG ELISA Kit"

EA101052

Produktdaten von Anti-Bordetella pertussis IgG ELISA Kit

Produkt-Kategorie ELISA Kits
Menge 1 kit
Synonyme Bordetella
Reaktivität Hu
Shipping to Europe, USA/Canada
PDF datasheet Datenblatt ansehen
Hersteller OriGene Technologies, Inc.

Datenblatt-Auszug

Add. information
Interference:
No significant interference observed with available related molecules.
Anwendung
Specificity:
Natural and recombinant human Anti-Bordetella pertussis IgG
Assay Type:
Solid Phase Sandwich ELISA
Signal:
Colorimetric
Sample Type:
Cell culture supernatant, serum, plasma
Sample Volume:
10 ul
Background Bordetella species are non-spore-forming encapsulated bipolar, coccoid (pale-staining) Gram-negative bacilli (about 0.3-0.5 µm thick and 1 µm long). The genus consists of the human parasites B. pertussis and B. parapertussis, and B. bronchiseptica which cause enzootic infections in various wild and domestic animal species.Bordetella pertussis produces a single-disease syndrome in man known as pertussis or whooping cough. It is a highly contagious childhood disease (approx. 80% of cases occur before the age of 5 years) which is transmitted by respiratory contact and is associated with a high mortality rate (about 1-2% in the first year of life, later on about 1%). In the absence of immunization, essentially no one escapes pertussis. Clinical pertussis is followed by natural acquired immunity which is long-lasting but not permanent. The distribution of the disease is worldwide, though clearly modified by immunization and other poorly defined social, economic, and nutritional factors. In most countries an active vaccination is recommended. Usually the immunization preparation is combined with diphtheria and tetanus toxoids.
Assaytime 3 hours
  • LinkedIn